Here at Marketplace, we report on economic data from the government all the time: stats on housing, the job market, inflation, and much more. They help us help you understand where the economy is and ...
BrainStorm Cell Therapeutics got the FDA advisory committee meeting it asked for but not the outcome it wanted. After a full day of presentations and testimonials, the panel of outside experts on ...
Daniel Schuman, an expert focused on federal government accountability and transparency, on Tuesday afternoon received an email from GSA that the committee was axed pursuant to a Trump executive order ...
I got a blood test as a newborn that changed the course of my life forever. The test, part of newborn screening performed on babies across the U.S. led to my being diagnosed with a rare inherited ...
Currently, the committee is made up of 11 members, including representatives from BlackRock, Deutsche Börse, Norges Bank, BNP Paribas, Bloomberg, and others. Stephen Dorrian, head of market data and ...
Lee, Romero, Bennett, Temte, Baker, and Levin are all past chairs of the U.S. Advisory Committee on Immunization Practices from 2003-2005 and 2009 to 2023. The recent postponement of a key federal ...
WASHINGTON, DC - FEBRUARY 13: U.S. President Donald Trump, accompanied by Robert F. Kennedy Jr. and his wife Cheryl Hines, speaks before Kennedy is sworn in as Secret (Photo by Andrew Harnik/Getty ...
Please provide your email address to receive an email when new articles are posted on . The FDA has terminated its Arthritis Advisory Committee, citing the panel’s infrequent meetings and the cost of ...
The Trump administration is disbanding expert advisory committees focused on space, climate, coastal area management and marine fisheries after the agency they were designed to assist said they are no ...
The aim of the Igniting Data Insights (IDI) initiative is to build a robust, secure and scalable data infrastructure that supports decision-making across campus and trains employees to use these tools ...
Today the U.S. Food and Drug Administration’s advisory committee gave the nod to donanemab, clearing the way for its marketing approval. All 11 members voted that the antibody was effective for people ...
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results